AgeX Therapeutics, Inc. (AGE)

Financing Cash Flow

$38.18M

TTM · Period ending: · USD

AGE logo

AGE Financing Cash Flow

Latest reported$38.18M
AGE TTM Cash from Financing ($6.00M → $38.18M)
High-resolution chart · PNG

AGE financing cash flow history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

AgeX Therapeutics, Inc. Financing Cash Flow — Trailing twelve months (TTM) (USD)
Period endingFinancing Cash Flow (USD)
38,184,000
38,552,000
17,412,000
23,415,000
20,424,000
14,854,000
12,665,000
8,181,000
6,728,000
8,728,000
17,500,000
17,000,000
16,000,000
16,000,000
6,000,000
5,750,000
6,750,000
6,250,000
7,246,000
6,988,000
6,965,000
8,272,000
5,961,000
6,256,000
4,766,000
1,950,000
6,265,000
4,978,000
4,754,000
9,763,000
6,000,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.